RNA干扰与抗肝纤维化治疗前景
The therapeutic prospect of RNA inference and anti-hepatic fibrosis
出处
《肝脏》
2004年第1期67-69,共3页
Chinese Hepatology
参考文献15
-
1Jorgensen RA, Cluster PD, English J, et al. Chalcone synthase cosuppression phenotypes in petunia flowers: comparison of sense vs. antisense constructs and single-copy vs. complex T-DNA sequences.Plant Mol Biol 1996, 31: 957-973
-
2Palauqui JC, Elmayan T, Pollien JM, et al. Systemic acquired silencing: transgene-specific post-transcriptional silencing is transmitted by grafting from sllenced stocks to non-silenced scions. EMBO J, 1998,16:4738-4745.
-
3Cheng JC, Moore TB, Sakamoto KM. RNA interference and human disease. Mol Genet Metab, 2003, 80: 122-128.
-
4Dooley S, Hamzavi J, Breitkopf K, et al. Smad7 prevents activation of hepatic stellate cells and liver fibrosis in rats. Gastroenterology,2003, 125: 178-191.
-
5Song E, Lee SK, Wang J, et al. RNA interference targeting Fas protects mice from fulminant hepatitis. Nat Med, 2003, 9: 347-351.
-
6Kapadia SB, Brideau-Andersen A, Chisari FV. Interference of hepatitis C virus RNA replication by short interfering RNAs. Proc Natl Acad Sci USA, 2003, 100:2014-2018.
-
7Lee NS, Dohjima T, Bauer G, et al. Expression of small interfering RNAs targeted against HIV-1 rev transcripts in human cells. Nature Biotechnol, 2002, 20: 500-505.
-
8Blom IE, Goldschmeding R, Leask A. Gene regulation of connective tissue growth factor: new targets for antifibrotic therapy? Matrix Biol, 2002, 21: 473-482.
-
9Rachfal AW, Brigstock DR. Connective tissue growth factor (CTGF/CCN2) in hepatic fibrosis. Hepatol Res, 2003, 26: 1-9.
-
10Guo S, Kempheus KJ. Par-l, a gene required for establishing polarity in C. elegans embryos, encodes a putative Ser/Thr kinase that is asymmetrically distributed. Cell, 1995, 81:611-620.
-
1李光明,李定国.RNA干扰与抗肝纤维化治疗前景[J].中国生物学文摘,2005,19(5):43-44.
-
2国荣,高广道.RNAi在心血管疾病中的应用研究[J].国际心血管病杂志,2007,34(5):363-366.
-
3李阳,谢幸.RNA干扰在哺乳动物病毒感染中的作用[J].国际流行病学传染病学杂志,2009,36(2):140-142.
-
4丁浩,冯涛.PPARγ及其在巨噬细胞中的作用[J].生命的化学,2005,25(5):377-379. 被引量：1
-
5仲威,严金川.miR-145在动脉粥样硬化发展中的作用[J].中国动脉硬化杂志,2015,23(5):522-526. 被引量：5
-
6一种干扰靶基因表达的复合分子及其制备方法[J].药物生物技术,2011,18(1):20-20.
-
7王欢,黄敏.RNAi技术研究进展及其基因治疗应用前景[J].现代诊断与治疗,2008,19(5):291-295. 被引量：5
-
8任金帅,宋茂民.RNA干扰技术及其在胰腺癌研究中的应用[J].中国医师进修杂志（外科版）,2007,30(10):69-70.
-
9伍明,范学军.缺氧诱导因子-1α在颈动脉粥样硬化发病机制中的研究[J].实用预防医学,2009,16(2):626-628.
-
10甘露路,杨文慧,何燕,王勤,刘师节,张帆,杨莉.低氧诱导因子与肝脏脂质代谢异常的相关性研究进展[J].心血管病学进展,2017,38(1):91-94. 被引量：3
